To bring a biomedical innovation to market takes an extraordinary amount of amount of effort, expertise, and resources. The Center for Biotechnology focuses on addressing two specific gaps in the development cycle. The first is from within the academic research community, working with faculty to move innovation beyond the discovery stage to address key scientific or technical questions that will be relevant to commercial partners or serve as the basis for company formation (BioREACH). The second is focused on building university/industry partnerships that support the company to reach commercially relevant value inflection milestones (Applied Research and Development Program – ARAD).
The Center for Biotechnology’s BioREACH award program is designed to bridge the critical gap between discovery and real-world application. The BioREACH program advances SBU innovations that have the potential to shape the future of health and healthcare by funding translational studies that address the key scientific or technical questions standing between an academic innovation and its next stage of development. Only Stony Brook University based innovators are eligible for the program.
Read more about the program, and access all 2026 application documents here.
2026 Application Deadline: October 29, 2026, 5:00pm ET
Fueling collaborations that move biotech forward
The Center for Biotechnology (CfB) co-sponsors collaborations between New York biotechnology companies and Stony Brook University (SBU) faculty, on a competitive basis, to help companies reach strategic technology development milestones that will unlock commercial opportunities.
Applications are accepted on a rolling basis and will be reviewed within three determined review cycles per year corresponding to the following deadlines: January 15th, May 15th and September 15th. Applications are subject to availability of award funds during that fiscal period.
Detailed information on the proposal process as well as the program application can be found within the forms pages linked below. A single PDF version of the proposal and letter of support should be submitted to the Center for Biotechnology at center_for_biotechnology@stonybrook.edu.
The Technology Commercialization Clinic provides business development and strategic planning services, as well as market data, competitive intelligence, intellectual property analyses and actionable recommendations to accelerate technology commercialization efforts. The object of the clinic is to identify and mitigate risks of early stage technology commercialization and to position clients to secure financing, including SBIR/STTR awards, angel investment, and venture. Typical outcomes from the clinic include evaluation of market opportunities, assessment of competitive landscape, Identification of technological advantages, strengthened business plans and investor presentations and improved commercialization strategies.
Technology Commercialization Clinic clients include start-up and emerging bioscience companies, entrepreneurial faculty and technologists, as well as technology transfer offices across NYS. There is no cost to participate in the Technology Commercialization Clinic.
Any company interested in participating in the Technology Commercialization Clinic, or any Center for Biotechnology program, must complete our intake form here. Once complete, a member of the CFB team will follow up for an intake discussion if appropriate.
In an effort to facilitate industry-academic interactions and research collaborations, we host periodic BioPartnering Meetings between corporate clients and a series of relevant academic faculty at Stony Brook University and other partner institutions. Faculty members are identified to present their research capabilities and technologies to the corporate client under a confidentiality agreement.
Often through our BioPartnerings, we facilitate corporate sponsored research projects. Once a company and faculty member are matched, we can assist in setting up the project and provide significant cost savings through reduced indirect cost rates and other efficiencies.